DRDO's anti-Covid drug 2-DG will reduce oxygen dependency: Harsh Vardhan
Union
Health Minister Dr Harsh Vardhan on
Monday said that the recovery time from COVID-19
infection and oxygen dependency will be reduced by anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence
Research and Development Organisation (DRDO).
While
speaking at the release ceremony of the first batch of the Covid 2-DG drug, Vardhan said,
"With the support of DRDO and in the leadership of Union Defence Minister
Rajnath Singh, this (anti-COVID drug 2DG) may be our first indigenous
research-based outcome to fight against COVID-19. It will reduce recovery time
and oxygen dependency."
"I
hope that this drug will serve the world and not just India in the fight
against COVID-19 in the coming days," he further said.
"We
have been combating COVID-19 for the past year and our scientists have
developed the vaccine and made it available to the public. I thank and
congratulate DRDO and its scientists. We have seen that under Prime Minister
Modi's leadership DRDO has played an important role in the fight against
COVID-19," he added. Read More
Comments
Post a Comment